PAXZANTO
Live / Registered — Registered (as of 18 Aug 2020)
What this means for you
Registered since 18 Aug 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88533073
- Registration number
- 6127829
- Mark type
- Stylized text
- Filed
- 24 Jul 2019
- Published for opposition
- 02 Jun 2020
- Registered
- 18 Aug 2020
- Attorney of record
- Evan A. Raynes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products and preparations for human use for the treatment and prevention of cancer, craniosynostosis, achondroplasia, and tenosynovial giant cell tumors; pharmaceutical products and preparations for the treatment of cancer
Owner
- BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL, ALLSCHWIL, CH
- Basilea Pharmaceutica International AG, Basel, CH
- Basilea Pharmaceutica International AG, Basel, CH
- Basilea Pharmaceutica International AG, Basel, CH
Prosecution history
- 18 Aug 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 28 Jun 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 18 Aug 2020 — REGISTERED-PRINCIPAL REGISTER
- 02 Jun 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Jun 2020 — PUBLISHED FOR OPPOSITION
- 13 May 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Apr 2020 — ELECTRONIC RECORD REVIEW COMPLETE
- 24 Apr 2020 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 17 Apr 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Apr 2020 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 16 Apr 2020 — LETTER OF SUSPENSION E-MAILED
- 16 Apr 2020 — SUSPENSION LETTER WRITTEN
- 10 Apr 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Apr 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Apr 2020 — ASSIGNED TO LIE